Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.
Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.
复制标题
改进 T 淋巴细胞克隆测定,以量化人类体内硫鸟嘌呤抗性突变频率。
DOI:
10.1093/mutage/2.2.87
复制
发表时间:
1987
期刊:
影响因子:
2.7
通讯作者:
Albertini,RJ
中科院分区:
文献类型:
--
作者:
O'Neill,JP;McGinniss,MJ;Berman,JK;Sullivan,LM;Nicklas,JA;Albertini,RJ
Cell cloning by limiting dilution in 96-well microtiter plates has been employed to isolate colonies of human T-lymphocytes resistant to the purine analogue, 6-thioguanine (TG). These colonies show stability of the TG-resistant (TGr) phenotype, lack hypoxanthine guanine phosphoribosyl transferase (HPRT) activity and thus appear to be the result ofin vivosomatic cell mutation events. In order to employ this T-lymphocyte cloning assay for quantitative determination of thein vivoTGrmutant frequency in humans, we have defined the optimal conditions for T-cell colony formation with both nonselected and TG-selected cells. The parameters investigated include medium, serum, amount of the mitogen phytohaemagglutinin, amount of T-cell growth factor (TCGF) and the number of irradiated feeder or accessory cells. Under the optimal conditions, the fraction of positive wells is proportional to the number of cells plated per well with both nonselection and TG selection conditions. T-cell cloning efficiencies therefore are independent of inoculum size. There was some evidence for a decline in TGrmutant cell cloning at densities >2 × 104cells per round-bottom well, possibly due to metabolic cooperation between wild-type and mutant cells. The conditions defined in this study appear to provide a quantitative measurement of thein vivoTGrmutant frequency in human T-lymphocytes.